European public procurement and grants data from official registers · Data as of 17 November 2026; updated daily.

Tenders

Pharmaceutical tenders in Austria

Pharmaceutical tenders in Austria: 447 listed on GranTender since 2024. The median awarded contract value is about €73,000 (403 contracts with a stated value). Buyers with the most tenders: Magistrat der Stadt Wien MA 15 - Gesundheitsdienst (174), Land Oberösterreich - Amt der Landesregierung/Direktion Präsidium/Abteilung Informationstechnologie (37) and Landeskrankenanstalten-Betriebsgesellschaft - KABEG (20); suppliers with the most contract awards: Merck Sharp & Dohme Gesellschaft m.b.H. (155), SANOFI-AVENTIS GmbH (144) and Richter Pharma AG (19). Sources: Kerndaten (data.gv.at) and TED. In 2025 the median contract value was €69,000; 78% of contracts drew a single bid (1.8 bids on average). Data as of 17 November 2026; updated daily.

Tenders
447
Open tenders
0
Awards
460
Awarded value awarded
€262,277,252
Awarded value framework ceiling
€64,353,912
Median contract value awarded
≈ €73,000
Average bids per contract
1.7
Tenders in 2025
249 +165% on 2024

Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.

Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.

Open tenders

No records yet.

Latest tenders

TenderBuyerEstimated valueStatusPublished
Rahmenliefervereinbarung Abecma, BreyanziLandeskrankenanstalten-Betriebsgesellschaft - KABEG—Awarded2 November 2026
Lieferung von Influenza-Impfstoffen für die Republik ÖsterreichBundesministerium für Soziales, Gesundheit, Pflege und Konsumentenschutz—Awarded27 October 2026
RV Produkt ZolbetuximabLandeskrankenanstalten-Betriebsgesellschaft - KABEG—Cancelled13 October 2026
RV Produkt PembrolizumabLandeskrankenanstalten-Betriebsgesellschaft - KABEG—Cancelled13 October 2026
AM_Lieferung eines Lutetium-177-PSMA-RadioligandentherapeutikumsGemeinnützige Salzburger Landeskliniken Betriebsgesellschaft mbH—Closed6 October 2026
Niedermolekulare Heparine in der FertigspritzeAllgemeine Unfallversicherungsanstalt (AUVA)—Awarded29 September 2026
DBS Paracetamol 2027Tirol Kliniken GmbH—Closed27 September 2026
Monoklonale RSV-Antikörper NirsevimabLand Niederösterreich - Amt der Landesregierung/Abteilung GS1 (Gesundheitswesen)—Awarded24 September 2026
Monoklonale RSV-Antikörper NirsevimabLand Niederösterreich - Amt der Landesregierung/Abteilung GS1 (Gesundheitswesen)—Awarded24 September 2026
Impfstoffbestellung für Klinikum VB, BeyfortusLand Oberösterreich - Amt der Landesregierung/Direktion Präsidium/Abteilung Informationstechnologie—Awarded23 September 2026
Rahmenvertrag über die Lieferung von Fibrinogenkonzentraten aus Humanplasma zur intravenösen AnwendungNÖ Landesgesundheitsagentur—Awarded23 September 2026
Impfstoffbestellung Beyfortus für Phönix, gesamt 300 DosenLand Oberösterreich - Amt der Landesregierung/Direktion Präsidium/Abteilung Informationstechnologie—Awarded22 September 2026
Monoklonale RSV-Antikörper NirsevimabLand Niederösterreich - Amt der Landesregierung/Abteilung GS1 (Gesundheitswesen)—Awarded21 September 2026
Impfstoffbestellung für Herba, BeyfortusLand Oberösterreich - Amt der Landesregierung/Direktion Präsidium/Abteilung Informationstechnologie—Awarded21 September 2026
Monoklonale RSV-Antikörper NirsevimabLand Niederösterreich - Amt der Landesregierung/Abteilung GS1 (Gesundheitswesen)—Awarded21 September 2026
Monoklonale RSV-Antikörper Nirsevimab (Beyfortus 50mg)Land Niederösterreich - Amt der Landesregierung/Abteilung GS1 (Gesundheitswesen)—Awarded16 September 2026
Impfstoffbestellung für Kwizda, Beyfortus 100mg, 200 DosenLand Oberösterreich - Amt der Landesregierung/Direktion Präsidium/Abteilung Informationstechnologie—Awarded15 September 2026
Impfstoffbestellung für KH Ried, 200 Dosen Beyfortus 50 mg.Land Oberösterreich - Amt der Landesregierung/Direktion Präsidium/Abteilung Informationstechnologie—Awarded14 September 2026
ImpfstoffbestellungLand Vorarlberg (Sanitätsangelegenheiten)—Awarded11 September 2026
Monoklonale RSV-Antikörper Nirsevimab (Beyfortus 50mg)Land Niederösterreich - Amt der Landesregierung/Abteilung GS1 (Gesundheitswesen)—Awarded11 September 2026

Competition and prices

In 2025, half of the contracts were worth between €52,000 and €130,000, with a median of €69,000 (237 contracts with a stated awarded value). Contracts drew 1.8 bids on average (median 1) and 78% drew a single bid — based on 152 contracts with a known number of bids. Compared with 2024, in 2025 the median value fell 5% and the share of single-bid contracts fell from 80% to 78%. The usual procedures: open procedure (58%), negotiation without a call for competition (36%), negotiated procedure (4%) — of 441 tenders with a stated procedure.

The most contracts went to Merck Sharp & Dohme Gesellschaft m.b.H. (155), SANOFI-AVENTIS GmbH (144) and Richter Pharma AG (19) — together 69% of all contracts.

YearContractsMedian valueMiddle half of valuesBids on averageSingle bid
2024101€73,000€55,000 – €270,0001.680% (70)
2025271€69,000€52,000 – €130,0001.878% (152)
2026 (so far)87€77,000€55,000 – €150,0001.097% (31)
All years460€73,000€55,000 – €140,0001.781% (254)

Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.

Where you have a chance

Since 1 November 2024, 79% of the 199 contracts with a known number of bids had a single bid; the median was 1 bid. The number of bids is known for 199 of the 237 contracts from procedures with competition.

Buyers who often get few offers

The buyers below usually received one or two offers per contract — an offer from you would stand out.

In the last 12 months, 7 companies won their first contract in our records here — 5% of the 150 contracts (our records start on 1 January 2024).

Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.

Main CPV divisions

CPV codes of this topic

  • 33600000 Pharmaceutical products

A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.

Medicines and pharmaceuticals in neighbouring countries

Today, 1,727 tenders in the same niche are open in neighbouring countries.

Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.

Expected soon3

ExpectedBuyerWhatWhy we expect itConfidence
now – Dec 2026
contract ends
Tirol Kliniken GmbHMedicines and pharmaceuticals
DBS Biosimilars
Typical value: ≈ €130,000
The current contract with Pfizer Corporation Austria GmbH ends on 31 December 2026; no new tender has been published yet.
Earlier tenders: 09/2025
high
Jan – Feb 2027
every year
Tirol Kliniken GmbHMedicines and pharmaceuticals
Belieferung der Auftraggeberin mit Trastuzumab
The buyer has published pharmaceutical tenders every year in January since 2025.
Earlier tenders: 02/2026, 01/2025
medium
Apr – Sep 2027
contract ends
Bundesbeschaffung GmbHMedicines and pharmaceuticals
Monoklonale RSV-Antikörper Nirsevimab
Typical value: ≈ €38m
The current contract with SANOFI-AVENTIS GmbH ends on 9 October 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 01/2025
medium

Forecast from public data, not an announcement. Methodology.

Market reports

Medicines and pharmaceuticals by city

Medicines and pharmaceuticals in other countries

Medicines and pharmaceuticals across Europe

Topics in Health, medical equipment and medicines

Questions and answers

Where can I find pharmaceutical tenders in Austria?
GranTender lists them in one place, from Kerndaten (data.gv.at) and TED, with their buyers, winners and contract values. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
Who wins the most pharmaceutical tenders in Austria?
By number of contracts won: Merck Sharp & Dohme Gesellschaft m.b.H. (155), SANOFI-AVENTIS GmbH (144), Richter Pharma AG (19).
Which buyers publish the most pharmaceutical tenders in Austria?
By number of tenders: Magistrat der Stadt Wien MA 15 - Gesundheitsdienst (174), Land Oberösterreich - Amt der Landesregierung/Direktion Präsidium/Abteilung Informationstechnologie (37), Landeskrankenanstalten-Betriebsgesellschaft - KABEG (20).
Which CPV codes belong to “Medicines and pharmaceuticals”?
33600000 Pharmaceutical products; plus tenders without a usable CPV code whose title names the topic.
How many bids do pharmaceutical tenders in Austria receive on average?
In 2025, contracts drew 1.8 bids on average (median 1) and 78% drew a single bid — based on 152 contracts with a known number of bids.
How much are contracts for pharmaceutical tenders in Austria worth?
In 2025, half of the contracts were worth between €52,000 and €130,000, with a median of €69,000 (237 contracts with a stated awarded value). Compared with 2024, in 2025 the median value fell 5% and the share of single-bid contracts fell from 80% to 78%.
Which procedures are used for pharmaceutical tenders in Austria?
The usual procedures: open procedure (58%), negotiation without a call for competition (36%), negotiated procedure (4%) — of 441 tenders with a stated procedure.
Which buyers get few offers in pharmaceutical tenders in Austria?
Since 1 November 2024, these buyers usually received one or two offers per contract: Magistrat der Stadt Wien MA 15 - Gesundheitsdienst (median 1 bid over 90 contracts), Tirol Kliniken GmbH (median 2 bids over 12 contracts) and Land Oberösterreich - Amt der Landesregierung/Direktion Präsidium/Abteilung Informationstechnologie (median 1 bid over 6 contracts). Since 1 November 2024, 79% of the 199 contracts with a known number of bids had a single bid; the median was 1 bid.

CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.